David Friend
Chief Scientific OfficerDr. David Friend, Ph.D., has been Chief Scientific Officer of Daré Bioscience, Inc. since June 06, 2018. Dr. Friend served as Senior Vice President of Product Development at Evofem, Inc. since April 1, 2015. Prior to joining Evofem, Dr. Friend served as Director of Product Development at CONRAD, an organization that works to expand contraceptive choices and prevent sexually transmitted infections. Before CONRAD, he served as Vice President of Research at Vyteris, Inc, a company that develops novel transdermal delivery systems. He has developed oral dosage forms for delivery of drugs and he holds several patents for novel pharmaceutical product dosage forms. His previous professional experience includes work at a number of pharmaceutical companies, including Delsys Pharmaceutical, a division of Elan Corporation, Vascular Therapeutics, CIBUS Pharmaceuticals and SRI International. He has published more than 60 research articles and is on the Editorial Board of the Drug Delivery and Translational Research, Antiviral Research and Pharmaceutical Development and Technology Journals. Additionally, he sits on three scientific advisory boards in the areas of microbicide development and the prevention of HIV transmission. Dr. Friend earned his Bachelor of Science in Biochemistry from the University of California, Davis, and his PhD in Chemistry from the University of California, Berkeley.
Positions
- Company NameDaré Bioscience, Inc.Stock CodeDAREPositionChief Scientific OfficerColleagues
- SMSabrina Martucci JohnsonCEO, President, Principal Financial Officer, Secretary & Director
- WHWilliam H. RastetterIndependent Chairman of the Board
- MJMarDee J. Haring-LaytonChief Accounting Officer
- MWMark WaltersVice President of Operations
- JKJennifer KiangVice President of Corporate Affairs & Development
- SLSusan L. KelleyIndependent Director
- GWGregory W. MatzIndependent Director
- RJRobin J. SteeleIndependent Director
